94 related articles for article (PubMed ID: 1504403)
1. Weight gain associated with cinnarizine.
Navarro-Badenes J; Martínez-Mir I; Palop V; Rubio E; Morales-Olivas FJ
Ann Pharmacother; 1992; 26(7-8):928-30. PubMed ID: 1504403
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
[TBL] [Abstract][Full Text] [Related]
3. New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study.
Pianese CP; Hidalgo LO; González RH; Madrid CE; Ponce JE; Ramírez AM; Morán LM; Arenas JE; Rubio AT; Uribe JO; Abiuso J; Hanuch E; Alegría J; Volpi C; Flaskamp R; Sanjuán AP; Gómez JM; Hernández J; Pedraza A; Quijano D; Martínez C; Castañeda JR; Guerra OJ; F GV
Otol Neurotol; 2002 May; 23(3):357-63. PubMed ID: 11981396
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cinnarizine in the prophylaxis of migraine in children: a double-blind placebo-controlled randomized trial.
Ashrafi MR; Salehi S; Malamiri RA; Heidari M; Hosseini SA; Samiei M; Tavasoli AR; Togha M
Pediatr Neurol; 2014 Oct; 51(4):503-8. PubMed ID: 25023977
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and therapeutic experience in 151 consecutive protocolized cases with vertigo syndrome of cervical origin. Comparative study of a cinnarizine and dihydroergocristine combination with a cinnarizine and dihydroergocristine plus anti-inflammatory agents combination].
Bartual J; Vidal J; Magro E; Roquette J
Acta Otorrinolaringol Esp; 1988; 39(5):331-8. PubMed ID: 3152492
[No Abstract] [Full Text] [Related]
6. [Comparative efficacy of betaserc and cinnarizine of vertigo in patients with migraine].
Amelin AV; Skoromets AA; Gonchar MA; Tumelevich BCh; Nikitin KA
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(5):43-8. PubMed ID: 12789824
[TBL] [Abstract][Full Text] [Related]
7. [Effect of cinnarizine on various types of vertigo. Clinical and electronystagmographic results of a double-blind study].
Hausler R; Sabani E; Rohr M
Acta Otorhinolaryngol Belg; 1989; 43(2):177-85. PubMed ID: 2690563
[TBL] [Abstract][Full Text] [Related]
8. Tardive blepharospasm associated with cinnarizine use.
Alonso-Navarro H; Jiménez-Jiménez FJ
Clin Neuropharmacol; 2006; 29(4):187-9. PubMed ID: 16855418
[TBL] [Abstract][Full Text] [Related]
9. [Akathisia, parkinsonism and depression induced by cinnarizine: a case report].
Stucchi-Portocarrero S; Vega-Dienstmaier JM; Saavedra JE; Sagástegui A
Rev Neurol; 1999 May 1-15; 28(9):876-8. PubMed ID: 10390751
[TBL] [Abstract][Full Text] [Related]
10. The effects of cinnarizine versus sodium valproate in migraine prophylaxis.
Bostani A; Rajabi A; Moradian N; Razazian N; Rezaei M
Int J Neurosci; 2013 Jul; 123(7):487-93. PubMed ID: 23311688
[TBL] [Abstract][Full Text] [Related]
11. Cinnarizine is a useful and well-tolerated drug in the treatment of acquired cold urticaria (ACU).
Tosoni C; Lodi-Rizzini F; Bettoni L; Toniati P; Zane C; Capezzera R; Venturini M; Calzavara-Pinton P
Eur J Dermatol; 2003; 13(1):54-6. PubMed ID: 12609783
[TBL] [Abstract][Full Text] [Related]
12. [Vertigo. Evidence based therapy of dizziness].
MMW Fortschr Med; 2010 Nov; 152(47):52-3. PubMed ID: 21226379
[No Abstract] [Full Text] [Related]
13. Cinnarizine-induced parkinsonism: ten years later.
Martí-Massó JF; Poza JJ
Mov Disord; 1998 May; 13(3):453-6. PubMed ID: 9613736
[TBL] [Abstract][Full Text] [Related]
14. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
Teive HA; Troiano AR; Germiniani FM; Werneck LC
Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
[TBL] [Abstract][Full Text] [Related]
15. Treatment of vertebrobasilar insufficiency--associated vertigo with a fixed combination of cinnarizine and dimenhydrinate.
Otto V; Fischer B; Schwarz M; Baumann W; Preibisch-Effenberger R
Int Tinnitus J; 2008; 14(1):57-67. PubMed ID: 18616088
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study.
Gil A; Nachum Z; Tal D; Shupak A
Clin Neuropharmacol; 2012; 35(1):37-9. PubMed ID: 22139622
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions to cinnarizine.
Bhatia RS
J Assoc Physicians India; 1989 Nov; 37(11):733. PubMed ID: 2632552
[No Abstract] [Full Text] [Related]
18. Movement disorders and depression due to flunarizine and cinnarizine.
Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
[TBL] [Abstract][Full Text] [Related]
19. Effect of food intake and co-administration of placebo self-nanoemulsifying drug delivery systems on the absorption of cinnarizine in healthy human volunteers.
Christiansen ML; Holm R; Abrahamsson B; Jacobsen J; Kristensen J; Andersen JR; Müllertz A
Eur J Pharm Sci; 2016 Mar; 84():77-82. PubMed ID: 26775868
[TBL] [Abstract][Full Text] [Related]
20. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
Negrotti A; Calzetti S
Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
